Mind Medicine (MindMed) Inc. (MNMD) Stock Forecast

MindMed Announces New Employee Inducement Grants

3d ago, source: Yahoo Finance

Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...

MindMed outlines 2026 Phase III trial readouts and advances MM120 commercialization with new CFO

on MSN ago, source: Seeking Alpha on MSN

Q2 2025 Management View CEO Robert Barrow highlighted that MindMed remains "on track with enrollment with our three pivotal Phase III trials for our lead asset, MM120 ODT, which is being evaluated in ...

Mind Medicine (MindMed) Inc. Announces Pricing of Public Offering

1y ago, source: Seeking Alpha

NEW YORK -- (BUSINESS WIRE)-- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to ...

Mind Medicine (MindMed) Inc. (MNMD) Q4 2023 Earnings Call Transcript

1y ago, source: Seeking Alpha

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Q4 2023 Earnings Conference Call February 28, 2024 8:00 AM ETCompany ParticipantsRob Barrow - Chief Executive ...

Mind Medicine (MindMed) Inc. Loss At -$34.74 Mln In Q4 - Nasdaq

5mon ago, source: Nasdaq

Mind Medicine (MindMed) Inc. Loss At -$34.74 Mln In Q4 March 06, 2025 — 07:10 am EST Written by RTTNews.com for RTTNews -> ...

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $26.33 Consensus ...

5mon ago, source: ETF Daily News

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has received a consensus rating of “Buy” from the thirteen ratings firms that are covering the company, Marketbeat Ratings reports.

Mind Medicine (MindMed) Inc. (MNMD): Among the Best Psychedelic Stocks ...

5mon ago, source: Insider Monkey

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) is a clinical-stage biopharma company focused on creating new treatments for brain health disorders and stands eighth among the 12 best psychedelic ...

Bank of New York Mellon Corp Boosts Stock Position in Mind Medicine ...

4mon ago, source: ETF Daily News

Bank of New York Mellon Corp boosted its holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Free Report) by 5.4% during the 4th quarter, according to its most recent disclosure with the ...

MindMed Announces New Employee Inducement Grants

1mon ago, source: The Bakersfield Californian

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health ...

Company	Ticker	90 Days Forecast	Market Cap. (USD M)	P/E	P/B
Ascend Wellness Holdings, Inc.	AAWH	Predict	132.67	None	4.85
AIBOTICS, INC.	AIBT	Predict	0.14	None	None
Ayr Wellness Inc.	AYRWF	Predict	0.00	None	0.00
biote Corp.	BTMD	Predict	388.34	15.74	-2.98
Niagen Bioscience, Inc.	CDXC	Predict	536.48	-666.15	11.64
Canopy Growth Corp	CGC	Predict	201.86	-0.33	0.41
Cronos Group Inc.	CRON	Predict	922.64	49.90	0.85
Curaleaf Holdings, Inc.	CURLF	Predict	2638.79	None	3.06
C21 Investments Inc.	CXXIF	Predict	45.82	None	1.60
CYANOTECH CORP	CYAN	Predict	3.04	-0.50	0.38
FITLIFE BRANDS, INC.	FTLF	Predict	119.64	19.28	3.07
Glass House Brands Inc.	GHBWF	Predict	22.30	None	0.19
Glass House Brands Inc.	GLASF	Predict	759.17	None	6.53
Glucose Health, Inc.	GLUC	Predict	0.41	None	None
Jushi Holdings Inc.	JUSHF	Predict	153.61	None	None
Mind Medicine (MindMed) Inc.	MNMD	Predict	857.93	-3.08	4.63
MANNATECH INC	MTEX	Predict	15.92	-55.42	2.10
Niagen Bioscience, Inc.	NAGE	Predict	825.85	46.58	12.87
NATURAL ALTERNATIVES INTERNATIONAL INC	NAII	Predict	26.16	-3.32	0.33
Cordyceps Sunshine Biotech Holdings Co., Ltd.	RAJAF	Predict	1020.08	None	None
Raphael Pharmaceutical Inc.	RAPH	Predict	4.32	None	None
SMART FOR LIFE, INC.	SMFL	Predict	0.00	0.00	0.00
Synergy CHC Corp.	SNYR	Predict	32.54	-551.25	-2.08
Trulieve Cannabis Corp.	TCNNF	Predict	1696.71	None	1.39
Tilray Brands, Inc.	TLRY	Predict	684.42	-4.14	0.25
UPEXI, INC.	UPXI	Predict	278.84	-10.63	150.67
USANA HEALTH SCIENCES INC	USNA	Predict	570.16	13.57	1.08